Mumbai, January 20, 2026 – Pfizer Limited (BSE: 500680, NSE: PFIZER) has announced key changes in its senior management structure, including the appointment of a new category lead for its vaccines business and realignment of leadership roles across portfolios, effective February 1, 2026.
Key Senior Management Changes
Pfizer Limited has appointed Mr. Nilesh Pendse as Category Lead – Vaccines, effective February 1, 2026. With this appointment, Mr. Pendse will join the company’s senior management team.At the same time, Mr. Manikantan Seshadrinathan, currently serving as Category Lead for Hospitals and Rare Disease, will transition to another role within the broader Pfizer group. He will cease to be part of Pfizer Limited’s senior...